Evidence map›Paper›PMID 35441379›Full record

ArticleClinical transplantation2022

Is it safe to expand the indications for split liver transplantation in adults? A single-center analysis of 155 in-situ splits.

Ngee-Soon Lau, Mark Ly, Ken Liu, Avik Majumdar, Simone I Strasser, Raaj K Biswas, Geoffrey W McCaughan, Michael Crawford, Carlo Pulitano

Open access · hybridAbstract read
In one paragraph

Article in Clinical transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ngee-Soon LauAustralian National Liver Transplantation Unit, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.ORCID 0000-0002-2254-8574
Mark LyAustralian National Liver Transplantation Unit, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.ORCID 0000-0001-8067-1573
Ken LiuAustralian National Liver Transplantation Unit, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.ORCID 0000-0002-0453-3168
Avik MajumdarAustralian National Liver Transplantation Unit, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.ORCID 0000-0003-2975-4327
Simone I StrasserAustralian National Liver Transplantation Unit, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.ORCID 0000-0001-6374-1525
Raaj K BiswasSydney Local Health District Clinical Research Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.ORCID 0000-0003-4294-6323
Geoffrey W McCaughanAustralian National Liver Transplantation Unit, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.ORCID 0000-0002-1483-1636
Michael CrawfordAustralian National Liver Transplantation Unit, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.ORCID 0000-0002-9194-5346
Carlo PulitanoAustralian National Liver Transplantation Unit, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.ORCID 0000-0002-4420-4107
The University of Sydney · AURoyal Prince Alfred Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSplit liver transplantation (SLT) enables two recipients to be transplanted using a single donor liver; typically, an adult and a child. Despite equivalent long-term outcomes to whole grafts in selected adults, the use of these grafts in high-risk adult recipients with high model for end-stage liver disease (MELD) scores (≥30), a poor pre-transplant clinical status (ICU or hospital-bound), acute liver failure or retransplantation remains controversial.

methodsWe retrospectively analyzed all deceased donor adult liver transplants performed between July 2002 and November 2019 at a single high-volume center and performed a propensity score-matched analysis. A subgroup analysis was performed to assess utility of these grafts for high-risk recipients.

resultsA total of 1090 adult liver transplants were performed, including 155 SLT (14%). Graft survival at 1-, 3- and 5-years were comparable between recipients of split and whole liver grafts (82%, 79% and 74% vs. 86%, 81% and 77%, respectively, log rank P = .537), as was patient survival at 1-, 3- and 5-years. Recipients of split grafts were more likely to have biliary complications and hepatic artery thrombosis, but equivalent long-term survival. Recipients with high MELD scores or a poor pre-transplant clinical status had similar patient and graft survival and complication profiles irrespective of whether they received split or whole grafts.

conclusionsSLT is an important method for addressing donor shortages and provides comparable long-term outcomes in adult recipients despite an increase in short-term complications. SLT use in high-risk recipients should be considered to allow for sickest-first allocation policies.

Indexed as

End Stage Liver DiseaseLiver TransplantationAdultChildGraft SurvivalHumansLiving DonorsRetrospective StudiesSeverity of Illness IndexTreatment Outcomehigh MELD scorehigh-risk recipientsplit liver transplantationurgent indication

Identifiers

PMID35441379
PMCPMC9541812
OpenAlexW4224211143

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.